Whitener Capital Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.05M Sell
5,665
-12
-0.2% -$4.11K 0.43% 51
2026
Q1
$2M Sell
5,677
-120
-2% -$42.8K 0.46% 49
2025
Q4
$1.9M Hold
5,797
0.43% 51
2025
Q3
$1.64M Sell
5,797
-1
-0% -$290 0.39% 58
2025
Q2
$1.62M Sell
5,798
-1,035
-15% -$293K 0.43% 56
2025
Q1
$2.13M Buy
6,833
+70
+1% +$20.7K 0.6% 42
2024
Q4
$1.76M Hold
6,763
0.49% 46
2024
Q3
$2.18M Sell
6,763
-200
-3% -$65.4K 0.62% 40
2024
Q2
$2.18M Buy
6,963
+22
+0.3% +$6.46K 0.66% 35
2024
Q1
$1.97M Buy
6,941
+38
+0.6% +$11.1K 0.65% 36
2023
Q4
$1.99M Sell
6,903
-15
-0.2% -$4.09K 0.72% 32
2023
Q3
$1.86M Buy
6,918
+57
+0.8% +$14.2K 0.74% 32
2023
Q2
$1.52M Sell
6,861
-102
-1% -$23.7K 0.58% 45
2023
Q1
$1.68M Sell
6,963
-75
-1% -$18.4K 0.7% 37
2022
Q4
$1.85M Buy
7,038
+79
+1% +$21.2K 0.81% 34
2022
Q3
$1.57M Sell
6,959
-223
-3% -$54.1K 0.74% 37
2022
Q2
$1.75M Sell
7,182
-69
-1% -$16.9K 0.79% 36
2022
Q1
$1.75M Buy
7,251
+55
+0.8% +$12.6K 0.66% 39
2021
Q4
$1.62M Buy
7,196
+1,296
+22% +$274K 0.58% 44
2021
Q3
$1.36M Sell
5,900
-238
-4% -$54.8K 0.62% 46
2021
Q2
$1.5M Buy
6,138
+238
+4% +$58.5K 0.6% 46
2021
Q1
$1.47M Hold
5,900
0.64% 46
2020
Q4
$1.36M Sell
5,900
-2,102
-26% -$485K 0.62% 46
2020
Q3
$2.03M Sell
8,002
-720
-8% -$178K 0.98% 24
2020
Q2
$2.06M Buy
8,722
+50
+0.6% +$11.4K 1.07% 20
2020
Q1
$1.76M Sell
8,672
-174
-2% -$38K 1.14% 20
2019
Q4
$2.13M Hold
8,846
1.11% 21
2019
Q3
$1.71M Sell
8,846
-136
-2% -$26.1K 0.94% 25
2019
Q2
$1.66M Buy
8,982
+2,610
+41% +$467K 0.94% 23
2019
Q1
$1.21M Sell
6,372
-1,845
-22% -$352K 0.79% 31
2018
Q4
$1.6M Buy
8,217
+2,010
+32% +$392K 1.18% 19
2018
Q3
$1.29M Buy
6,207
+302
+5% +$59.5K 0.84% 26
2018
Q2
$1.09M Buy
5,905
+42
+0.7% +$7.43K 0.86% 29
2018
Q1
$999K Buy
5,863
+1,958
+50% +$359K 0.76% 32
2017
Q4
$679K Buy
+3,905
New +$691K 0.58% 49

Other funds holding AMGN

Whitener Capital Management's AMGN Position: Q2 2026 in Review

Whitener Capital Management reduced its Amgen (AMGN) stake by 0.21% in Q2 2026, selling an estimated $4.11K and leaving 5,665 shares worth $2.05M. The position accounts for 0.43% of the portfolio, ranked #51.

Whitener Capital Management first reported a position in AMGN in Q4 2017 and has held it in 35 quarters since. The position peaked at $2.18M in Q3 2024. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Whitener Capital Management held 5,665 shares of Amgen worth $2.05M as of Q2 2026.
  • Whitener Capital Management sold 12 Amgen shares in Q2 2026, an estimated $4.11K.
  • Amgen made up 0.43% of Whitener Capital Management's portfolio in Q2 2026, its #51 holding.
  • Whitener Capital Management first reported a position in Amgen in Q4 2017 and has held it in 35 quarters since.
  • Whitener Capital Management's Amgen position peaked at $2.18M in Q3 2024.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Whitener Capital Management's 13F filing for Q2 2026, filed 10 Jul 2026.